Bruce Rogers - Apr 17, 2023 Form 4 Insider Report for Morphic Holding, Inc. (MORF)

Role
President
Signature
/s/ Robert Farrell as attorney-in-fact for Bruce Rogers
Stock symbol
MORF
Transactions as of
Apr 17, 2023
Transactions value $
-$360,312
Form type
4
Date filed
4/19/2023, 07:06 PM
Previous filing
Feb 16, 2023
Next filing
Apr 27, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MORF Common Stock Options Exercise $43.2K +10K +8.54% $4.32* 127K Apr 17, 2023 Direct F1
transaction MORF Common Stock Sale -$403K -10K -7.87% $40.35 117K Apr 17, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MORF Stock Option (right to buy Common Stock) Options Exercise $0 -10K -7.24% $0.00 128K Apr 17, 2023 Common Stock 10K $4.32 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Includes 863 shares of Common Stock acquired under the issuer's employee stock purchase plan on February 28, 2023.
F2 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F3 The option is fully vested.